Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-18

Clinical Trial Update: A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence [Phase 2]

View source ↗

Summary

Phase 2 double-blind trial investigating psilocybin-assisted treatment for alcohol dependence has completed; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • psilocybin-assisted treatment (psilocybin)

Snippet

Sponsor: NYU Langone Health | Conditions: Alcohol Dependence | Phase 2 | Status: COMPLETED | Results posted: 2022-10-18